238 related articles for article (PubMed ID: 21665436)
21. Distinct autoantibody profiles in systemic lupus erythematosus patients are selectively associated with TLR7 and TLR9 upregulation.
Chauhan SK; Singh VV; Rai R; Rai M; Rai G
J Clin Immunol; 2013 Jul; 33(5):954-64. PubMed ID: 23564191
[TBL] [Abstract][Full Text] [Related]
22. Comparison of human B cell activation by TLR7 and TLR9 agonists.
Hanten JA; Vasilakos JP; Riter CL; Neys L; Lipson KE; Alkan SS; Birmachu W
BMC Immunol; 2008 Jul; 9():39. PubMed ID: 18652679
[TBL] [Abstract][Full Text] [Related]
23. Autoimmune skin inflammation is dependent on plasmacytoid dendritic cell activation by nucleic acids via TLR7 and TLR9.
Guiducci C; Tripodo C; Gong M; Sangaletti S; Colombo MP; Coffman RL; Barrat FJ
J Exp Med; 2010 Dec; 207(13):2931-42. PubMed ID: 21115693
[TBL] [Abstract][Full Text] [Related]
24. Immune complex negatively regulates Toll-like receptor 9-mediated immune responses in B cells through the inhibitory Fc-gamma receptor IIb.
Qian L; Chen W; Qin H; Rui C; Jia X; Fu Y; Gong W; Tian F; Ji M
Microbiol Immunol; 2015 Mar; 59(3):142-51. PubMed ID: 25557539
[TBL] [Abstract][Full Text] [Related]
25. Interactions between TLR7 and TLR9 agonists and receptors regulate innate immune responses by astrocytes and microglia.
Butchi NB; Du M; Peterson KE
Glia; 2010 Apr; 58(6):650-64. PubMed ID: 19998480
[TBL] [Abstract][Full Text] [Related]
26. Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses.
Merlo A; Calcaterra C; Mènard S; Balsari A
J Leukoc Biol; 2007 Sep; 82(3):509-18. PubMed ID: 17586660
[TBL] [Abstract][Full Text] [Related]
27. TLR9-Activating CpG-B ODN but Not TLR7 Agonists Triggers Antibody Formation to Factor IX in Muscle Gene Transfer.
Butterfield JSS; Biswas M; Shirley JL; Kumar SRP; Sherman A; Terhorst C; Ling C; Herzog RW
Hum Gene Ther Methods; 2019 Jun; 30(3):81-92. PubMed ID: 31140323
[TBL] [Abstract][Full Text] [Related]
28. Heightened TLR7/9-Induced IL-10 and CXCL13 Production with Dysregulated NF-ҝB Activation in CD11c
Yim LY; Lau CS; Chan VS
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31546763
[TBL] [Abstract][Full Text] [Related]
29. Toll-like receptor 9-independent aggravation of glomerulonephritis in a novel model of SLE.
Yu P; Wellmann U; Kunder S; Quintanilla-Martinez L; Jennen L; Dear N; Amann K; Bauer S; Winkler TH; Wagner H
Int Immunol; 2006 Aug; 18(8):1211-9. PubMed ID: 16798839
[TBL] [Abstract][Full Text] [Related]
30. Different Spatial and Temporal Roles of Monocytes and Monocyte-Derived Cells in the Pathogenesis of an Imiquimod Induced Lupus Model.
Nomura A; Mizuno M; Noto D; Aoyama A; Kuga T; Murayama G; Chiba A; Miyake S
Front Immunol; 2022; 13():764557. PubMed ID: 35371102
[TBL] [Abstract][Full Text] [Related]
31. Lack of SIGIRR/TIR8 aggravates hydrocarbon oil-induced lupus nephritis.
Lech M; Skuginna V; Kulkarni OP; Gong J; Wei T; Stark RW; Garlanda C; Mantovani A; Anders HJ
J Pathol; 2010 Apr; 220(5):596-607. PubMed ID: 20112371
[TBL] [Abstract][Full Text] [Related]
32. Activation of dendritic cells via TLR7 reduces Foxp3 expression and suppressive function in induced Tregs.
Hackl D; Loschko J; Sparwasser T; Reindl W; Krug AB
Eur J Immunol; 2011 May; 41(5):1334-43. PubMed ID: 21469103
[TBL] [Abstract][Full Text] [Related]
33. Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes.
Boulé MW; Broughton C; Mackay F; Akira S; Marshak-Rothstein A; Rifkin IR
J Exp Med; 2004 Jun; 199(12):1631-40. PubMed ID: 15197227
[TBL] [Abstract][Full Text] [Related]
34. Immune complex enhances tolerogenecity of immature dendritic cells via FcγRIIb and promotes FcγRIIb-overexpressing dendritic cells to attenuate lupus.
Zhang Y; Liu S; Yu Y; Zhang T; Liu J; Shen Q; Cao X
Eur J Immunol; 2011 Apr; 41(4):1154-64. PubMed ID: 21360699
[TBL] [Abstract][Full Text] [Related]
35. Direct injection of plasmid DNA into the skin induces dermatitis by activation of monocytes through toll-like receptor 9.
Sawamura D; Abe R; Goto M; Akiyama M; Hemmi H; Akira S; Shimizu H
J Gene Med; 2005 May; 7(5):664-71. PubMed ID: 15655803
[TBL] [Abstract][Full Text] [Related]
36. The DNA sugar backbone 2' deoxyribose determines toll-like receptor 9 activation.
Haas T; Metzger J; Schmitz F; Heit A; Müller T; Latz E; Wagner H
Immunity; 2008 Mar; 28(3):315-23. PubMed ID: 18342006
[TBL] [Abstract][Full Text] [Related]
37. B-cell receptor for antigen modulates B-cell responses to complex TLR9 agonists and antagonists: implications for systemic lupus erythematosus.
Goeken JA; Layer T; Fleenor S; Laccheo M; Lenert P
Lupus; 2010 Oct; 19(11):1290-301. PubMed ID: 20605877
[TBL] [Abstract][Full Text] [Related]
38. Regulatory molecules required for nucleotide-sensing Toll-like receptors.
Saitoh S; Miyake K
Immunol Rev; 2009 Jan; 227(1):32-43. PubMed ID: 19120473
[TBL] [Abstract][Full Text] [Related]
39. Role of atopic status in Toll-like receptor (TLR)7- and TLR9-mediated activation of human eosinophils.
Månsson A; Cardell LO
J Leukoc Biol; 2009 Apr; 85(4):719-27. PubMed ID: 19129482
[TBL] [Abstract][Full Text] [Related]
40. Role of pathogenic auto-antibody production by Toll-like receptor 9 of B cells in active systemic lupus erythematosus.
Nakano S; Morimoto S; Suzuki J; Nozawa K; Amano H; Tokano Y; Takasaki Y
Rheumatology (Oxford); 2008 Feb; 47(2):145-9. PubMed ID: 18160420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
